Selonterra Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Research

Selonterra, Inc. California New York

About Selonterra, Inc.

Selonterra, Inc. (www.selonterra.com) pursues transformative approaches to the development of therapies of neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. We harness human genetics, molecular pathway analysis and gene regulatory networks to identify proprietary disease-causing mechanisms and molecular targets, and exploit these to discover effective therapeutics. Selonterra's founders and advisors are scientists and executives with decades of biotech and pharma experience complemented by a global network of collaborator companies.

Investor and Media Contact:
T: ([phone]
E: [e-mail]

Logo - https://mma.prnewswire.com/media/2017024/Selonterra_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/selonterra-awarded-second-grant-from-the-michael-j-fox-foundation-for-parkinsons-research-302267943.html